Navigation Links
Advanced Life Sciences Applies for FDA Orphan Drug Designation for ALS-886 to Treat Acute Lung Injury
Date:11/18/2010

nts for ARDS.  Because infection is often the underlying cause of ARDS, appropriate antibiotic therapy is administered. There are approximately 150,000 cases of ARDS in the United States annually and the mortality rate is approximately 50%. Patients who survive ARDS will typically experience ongoing mild to moderate impairment of lung function, with poorer health-related quality of life after hospitalization compared to patients who were hospitalized without ARDS.  

About ALS-886

ALS-886 is a small molecule therapeutic that, in preclinical studies, has demonstrated efficacy in both scavenging existing free radicals and sequestering free iron. The goal of treatment with ALS-886 for ARDS will be to reduce the tissue damage brought about by the free radicals in the lungs. Previous animal toxicology studies have demonstrated the safety and benign side effect profile of ALS-886. This could prove beneficial in the use of the compound in the critical care setting. In addition, the mild safety profile shown in animal studies supports the possibility that ALS-886 could be used as a prophylactic. That is, it could be administered to individuals who are at high risk of developing ARDS, such as patients suffering from sepsis or severe trauma, in order to prevent the underlying condition from leading to ARDS. ALS-886 may also have applicability for other conditions in which free radicals cause tissue damage, such as ischemic stroke and myocardial infarction. An open IND is in place to start Phase I clinical trials.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, Restanza™, is a novel once-a-day oral antibiotic in late-stage development for the treatment of respiratory tract infections including CABP
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 The spinal column is one of the ... carried to and from the brain through the column control ... Injury or ailment here can be life altering, and leave ... control over their body. Though back injury and disease can ... are more options available to make things better than ever ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- Inc. magazine today ... third straight year, No. 349 in Health on ... of the nation,s fastest-growing private companies. The list ... important segment of the economy—America,s independent entrepreneurs. Companies ... LinkedIn, Zillow, and many other well-known names gained ...
(Date:8/21/2014)... YORK , August 21, 2014 ... Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license ... software for plant breeders and researchers, today is ... a joint venture with Seach Ltd, a leading ... formed to research and develop new breeds of ...
Breaking Medicine Technology:Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... Medical Technologies, Inc. today announced that Allina Hospitals ... company,s integrated electronic health record (EHR) practice management ... across Minnesota and western Wisconsin. ... ability to interface tightly with Allina,s Epic-based electronic ...
... Aethlon Medical, Inc. (OTC Bulletin Board: ... to address infectious disease and cancer, announced today that ... PST on January 20, 2011 at the Hyatt Regency ... Village Drive, San Diego, California, 92122. (Photo: ...
Cached Medicine Technology:Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 2Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 3Aethlon Medical to Host Investor Event on January 20, 2011 2Aethlon Medical to Host Investor Event on January 20, 2011 3Aethlon Medical to Host Investor Event on January 20, 2011 4
(Date:8/22/2014)... August 22, 2014 AttorneyOne.com, a recognized ... the latest information from the FDA on Diamondback ... US FDA announced on August 19, that certain lots ... number DPB-125MICRO145 (Part number 7-10003), by Cardiovascular Systems, are ... sheaths that could fracture during use and could possibly ...
(Date:8/22/2014)... August 22, 2014 Reacting to naysayers ... Rich Plasma therapy (PRP), a top PRP therapy LA ... therapy has everything to do with practical well researched ... hype. PRP therapy is a new medical breakthrough technology ... and bones using the PRP therapy. , The Managing ...
(Date:8/22/2014)... 22, 2014 Teen substance abuse has long ... The rising numbers of young adults falling victim to a ... help make a difference in the community, the new Troubled ... for teens seeking to overcome their chemical dependency. The helpline ... best youth rehab center to focus on achieving sobriety. , ...
(Date:8/22/2014)... 22, 2014 The rising numbers of ... OH. Over the years, countless lives have been lost due ... difference in the community a new helpline was established to ... in Northeast Ohio who are seeking to overcome their chemical ... helpline at (300) 400-2616, parents and their teens can speak ...
(Date:8/22/2014)... Carolina Senior Living Apartments, owned and operated ... recently opened 30 spacious one-bedroom affordable residential units ... in Lexington, NC. Each unit is equipped with ... heating and cooling system, and secured entry. ... of a three-story building with an elevator and ...
Breaking Medicine News(10 mins):Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:MetroMD With The Help Of PRP Therapy Helps People Fight Hip Injuries 2Health News:New Helpline Provides Hope for Troubled Teens in Toledo 2Health News:Troubled Teens in Akron, OH Can Receive Assistance from New Helpline for Addiction Recovery 2Health News:United Church Homes and Services Announce New Affordable Housing Community for Seniors 2
... GP under a new scheme that has the potential to ... of repeat prescriptions between general practices and pharmacies is currently ... streamline the system and make it faster and more convenient ... errors. , And now the scheme is to be studied ...
... -- were diagnosed this year, American Cancer Society reports , , ... cut a deadly swath across the globe, with the American ... worldwide in 2007, with 7.6 million people dying from the ... , finds that 5.4 million of those cancers and 2.9 ...
... Dec. 17 STAAR Surgical,Company (Nasdaq: STAA ... invasive ophthalmic products, today announced that it has,borrowed ... senior,promissory note to fund its purchase of the ... venture was formed by STAAR, Canon Inc. and,Canon ...
... thousands of babies are born with severe heart defects that must ... though the odds for these infants are much better now than ... there may be a way to give them an even better ... most experienced at handling such cases. , In the first national ...
... vast majority of Americans forgo valuable end-of-life care ... terminally ill patients prepare for death, treating their symptoms and ... the end. , The patients maintain their dignity and some ... to help them come to terms with their impending loss. ...
... centimeter in size or smaller no more than 0.4 inch ... more intensive therapy than is routinely offered today, say researchers at ... presented at the San Antonio Breast Cancer Symposium, is one of ... tiny tumors that have not spread to the lymph nodes. The ...
Cached Medicine News:Health News:Prescription for an electronic revolution? 2Health News:Prescription for an electronic revolution? 3Health News:Cancer Killed Almost 8 Million Worldwide in 2007 2Health News:Cancer Killed Almost 8 Million Worldwide in 2007 3Health News:Cancer Killed Almost 8 Million Worldwide in 2007 4Health News:STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture 2Health News:STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture 3Health News:STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture 4Health News:For babies with heart defects, death risk is far lower at most experienced hospitals 2Health News:For babies with heart defects, death risk is far lower at most experienced hospitals 3Health News:For babies with heart defects, death risk is far lower at most experienced hospitals 4Health News:Hospice: An Overlooked Option 2Health News:Hospice: An Overlooked Option 3Health News:Even tiny breast tumors can be aggressive and may require maximum therapy 2Health News:Even tiny breast tumors can be aggressive and may require maximum therapy 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: